This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Chemical Technology. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Phil Hwan Kim: Innovator in High-Speed Drug Screening Technology
Introduction
Phil Hwan Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of drug screening technology. His innovative approach focuses on enhancing the efficiency and accuracy of drug analysis through advanced methodologies.
Latest Patents
One of Phil Hwan Kim's key inventions is a patent for a high-speed screening apparatus designed for Raman analysis-based multiple drug testing. This invention allows for the easy detection of Raman signals using a core-cap-shell nanoparticle that amplifies the Raman signal by ten times. The apparatus ensures high reproducibility through Raman spectroscopy, where materials do not interfere with each other, resulting in a spectrum with a sharp peak. This technology enables the screening of drugs at high speed without the need for movement between molecules within a sample. Additionally, the apparatus can utilize a CCD camera as a detector, allowing for multiple screenings of various drugs simultaneously, thanks to its capability of coating with five or more colors.
Career Highlights
Phil Hwan Kim is affiliated with the Korea Research Institute of Chemical Technology. His work there has been instrumental in advancing chemical technology and drug screening processes. His innovative contributions have positioned him as a key figure in the research community.
Collaborations
Phil Hwan Kim has collaborated with notable colleagues, including Haemi Lee and Hyung Min Kim. Their combined efforts have furthered research and development in the field of chemical technology.
Conclusion
Phil Hwan Kim's contributions to high-speed drug screening technology exemplify the impact of innovation in the field of chemical research. His work continues to influence advancements in drug analysis and screening methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
